Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

about

A safety evaluation of raltegravir for the treatment of HIV.Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region

P2860

Q47377203-6CA58D4B-F3E8-45D5-B7C0-7567C832671A Q56889430-692ED6D1-9A05-4461-8EAF-C89219EE3312

P2860

Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

Item

http://www.wikidata.org/entity/Q40103229

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

@en

type

Item

label

Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

@en

prefLabel

Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

@en

P1476

Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

@en

P2093

Michelle M Estrella

http://www.w3.org/2001/XMLSchema#string

Mohamed G Atta

http://www.w3.org/2001/XMLSchema#string

Vasantha Jotwani

http://www.w3.org/2001/XMLSchema#string

P2860

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy

APOL1 localization in normal kidney and nondiabetic kidney disease

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines.

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Dissecting How CD4 T Cells Are Lost During HIV Infection

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients: is it time to revise atazanavir dosages?

P31

scholarly article

P356

10.1681/ASN.2017040468

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28784698

http://www.w3.org/2001/XMLSchema#string

P921

HIV

P932

5661296

http://www.w3.org/2001/XMLSchema#string

Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

about

P2860

P2860

Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P921

P932